The Base of the Pyramid project is an initiative by Novo Nordisk to facilitate access to diabetes care for the working poor in low- and middle-income countries.
Around a third of the world’s population is lacking regular access to health care including essential medicines like insulin. This is especially an issue in low- and middle income countries which also is home to eighty percent of people living with diabetes today. However, diabetes as well as other non-communicable diseases continue to be under prioritised in development assistance for health (DAH).
The Base of the Pyramid project targets the over one billion people globally with low incomes, the working poor, who have difficulties accessing health services. These people have some disposable income, are accessible and could contribute to financing their own treatment.
The purpose of the Base of the Pyramid project is to create shared value by developing scalable, sustainable and profitable solutions that increase access to diabetes care for the working poor living in low- and middle-income countries as well as provide value to the business of Novo Nordisk.
The BoP project works to ensure:
The project was initiated in 2010
Geographical reach: Ghana, Kenya, Nigeria and Senegal
Partners: Primarily local health authorities and health care organisations
Four out of five people with diabetes live in low and middle income countries. In Kenya, the Base of the Pyramid project is identifying cross-sector collaboration to ensure good diabetes care for the thousands of people with diabetes in the country.
The diabetes epidemic is a global emergency in slow motion, where developing countries carry the biggest the burden. This film zooms in on challenges and progress made in Kenya to improve access to diabetes care.
A public-private partnership has significantly improved supply of insulin in Kenya and established a price ceiling.